Listened to this episode yesterday, it was really interesting. There is definetely something going with the manufactured spike being bioactive, having a lot of my work coleagues dealing with COVID-19 like symptoms after the jab, it is really hard to not connect the dots. But I'm having difficulty to acknowledge the evidence presented by Byram Brindle. I've downloaded said Pharmacokinetcis study done by Pfizer (disclosed by FOIAA request by B.B.), looked at the organ distribution table, and especially the relative dose table (on the right) does not sound alarming. Relative lipid concentrations are really small, could it be that FDA or EMA were also thinking that this is a no-issue? Also, how it could be, that the numbers don't add up? I mean, I would expect, that shortly after the injection, the % of administred dose in the injection site will be close to 100?